Atilotrelvir COVID-19 outcomes
November 2026
StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Lu (DB RCT)13%0.87 · 0.77–0.99no recov.610 (n)603 (n)
Lu (DB RCT)25%0.75 · 0.66–0.86viral+610 (n)607 (n)
00.511.52+